1984
H. Imagawa et al.
LETTER
the mixture was stirred for 20 min. To this was added a
Seeberger, P. H. Org. Lett. 2003, 5, 4717. (k) Mogemark,
M.; Gustafsson, L.; Bengtsson, C.; Elofsson, M.; Kihlberg,
J. Org. Lett. 2004, 6, 4885. (l) Love, K. R.; Seeberger, P. H.
Angew. Chem. Int. Ed. 2004, 43, 602. (m) Jaunzems, J.;
Kashin, D.; Schönberger, A.; Kirschning, A. Eur. J. Org.
Chem. 2004, 3435. (n) Ako, T.; Daikoku, S.; Ohtsuka, I.;
Kato, R.; Kanie, O. Chem. Asian J. 2006, 1, 798. (o) Kanie,
O.; Ohtsuka, I.; Ako, T.; Daikoku, S.; Kanie, Y.; Kato, R.
Angew. Chem. Int. Ed. 2006, 45, 3851. (p) Jonke, S.; Liu,
K.-g.; Schmidt, R. R. Chem. Eur. J. 2006, 12, 1274.
(q) Matsushita, T.; Hinou, H.; Fumoto, M.; Kurogochi, M.;
Fujitani, N.; Shimizu, H.; Nishimura, S.-I. J. Org. Chem.
2006, 71, 3051. (r) Doi, T.; Kinbara, A.; Inoue, H.;
solution of trichloroacetimidate 7 (936 mg, 1.47 mmol) in
CH2Cl2 (3 mL) using a syringe drive over a period of 1 h, and
the mixture was stirred for 12 h at the same temperature. The
reaction was terminated by the addition of Et3N (720 mg,
7.12 mmol). Insoluble material was removed by passing
through a cotton Celite pad, and the filtrate was concentrated
under reduced pressure. The resulting material was
dissolved in MeCN (100 mL) and adsorbed onto an ODS
column (20 g), and the polar byproducts were eluted with
MeCN (100 mL). Trisaccharide 8 (666 mg, 95% yield) was
recovered by the elution with CH2Cl2.
Compound 8: [a]D22 +41.5 (c 1.9, CHCl3). FT-IR (neat):
3087, 3062, 3004, 2925, 2855, 1951, 1878, 1809, 1745,
1611, 1585, 1511, 1496, 1454, 1368, 1285, 1237, 1132,
1101, 1050, 1026, 981, 913, 840, 736, 699, 604 cm–1. 1H
NMR (400 MHz, CDCl3): d = 0.89 (3 H, t, J = 6.8 Hz), 1.27–
1.46 (22 H, m), 1.74–1.81 (2 H, m), 2.01–2.07 (4 H, m), 2.09
(3 H, s), 2.17 (3 H, s), 3.61–3.70 (3 H, m), 3.73–3.78 (2 H,
m), 3.82–3.95 (11 H, m), 3.99 (1 H, dd, J = 9.2, 3.2 Hz), 4.03
(1 H, dd, J = 9.2, 3.2 Hz), 4.19 (1 H, dd, J = 9.6, 3.2 Hz),
4.31 (1 H, d, J = 11.6 Hz), 4.41–4.70 (12 H, m), 4.54 (1 H,
d, J = 11.6 Hz), 4.76 (1 H, d, J = 11.2 Hz), 4.83 (1 H, d,
J = 1.6 Hz), 4.88 (2 H, dd, J = 10.8, 3.2 Hz), 4.98 (1 H, d,
J = 2.0 Hz), 5.20 (1 H, d, J = 1.6 Hz), 5.33–5.41 (2 H, m),
5.50–5.52 (2 H, m), 6.75–6.78 (2 H, m), 7.12–7.35 (42 H,
m). 13C NMR (100 MHz, CDCl3): d = 14.4 (q), 21.3 (q), 21.5
(q), 22.3 (t), 26.3 (t), 27.4 (t), 29.5–30.0 (many t), 32.2 (t),
32.9 (t), 66.7 (t), 68.2 (t), 68.7 (d, 2 C), 68.9 (t), 69.0 (d), 69.2
(t), 71.5 (d), 71.6 (d, 2 C), 72.0 (t), 72.4 (d), 72.4 (t), 73.6 (t),
73.6 (t), 74.4 (d), 74.5 (d), 75.2 (t), 75.3 (d), 75.4 (t), 77.5 (d),
77.8 (d), 77.9 (d), 78.3 (d), 79.0 (d), 95.7 (d), 98.2 (d), 99.9
(d), 114.6 (d), 127.7–130.2 (many d), 138.0 (s), 138.1 (s),
138.1 (s), 138.3 (s), 138.5 (s), 138.5 (s), 138.8 (s), 138.9 (s),
159.0 (s), 170.4 (s), 170.6 (s). MS (FAB, m-NBA): m/z =
1689 [M + Na]+. HRMS (FAB): m/z calcd for C103H124O19Na
[M + Na]+: 1687.8635; found: 1687.8654.
Takahashi, T. Chem. Asian J. 2007, 2, 188. (s) Manabe, S.;
Ueki, A.; Ito, Y. Chem. Commun. 2007, 3673.
(4) (a) Ando, H.; Manabe, S.; Nakahara, Y.; Ito, Y. Angew.
Chem. Int. Ed. 2001, 40, 4725. (b) Egusa, K.; Kusumoto, S.;
Fukase, K. Synlett 2001, 777. (c) Ito, Y.; Manabe, S. Chem.
Eur. J. 2002, 8, 3077. (d) Egusa, K.; Kusumoto, S.; Fukase,
K. Eur. J. Org. Chem. 2003, 3435. (e) Hanashima, S.;
Manabe, S.; Ito, Y. Synlett 2003, 979. (f) MacCoss, R. N.;
Brennan, P. E.; Ley, S. V. Org. Biomol. Chem. 2003, 1,
2029. (g) Hanashima, S.; Manabe, S.; Inamori, K.-I.;
Taniguchi, N.; Ito, Y. Angew. Chem. Int. Ed. 2004, 43,
5674. (h) Komba, S.; Kitaoka, M.; Kasumi, T. Eur. J. Org.
Chem. 2005, 5313. (i) Fukase, K.; Takashina, M.; Hori, Y.;
Tanaka, D.; Tanaka, K.; Kusumoto, S. Synlett 2005, 2342.
(j) Hanashima, S.; Manabe, S.; Ito, Y. Angew. Chem. Int. Ed.
2005, 44, 4218. (k) Wu, J.; Guo, Z. J. Org. Chem. 2006, 71,
7067.
(5) The glycosylations using fluorous tags: (a) Curran, D. P.;
Ferritto, R.; Hua, Y. Tetrahedron Lett. 1998, 39, 4937.
(b) Goto, K.; Miura, T.; Mizuno, M.; Takaki, H.; Imai, N.;
Murakami, Y.; Inazu, T. Synlett 2004, 2221. (c) Jing, Y.;
Huang, X. Tetrahedron Lett. 2004, 45, 4615. (d) Miura, T.;
Inazu, T. Tetrahedron Lett. 2003, 44, 1819. (e) Manzoni,
L.; Castelli, R. Org. Lett. 2004, 6, 4195. (f) Mizuno, M.;
Matsumoto, H.; Goto, K.; Hamasaki, K. Tetrahedron Lett.
2006, 47, 8831. (g) The glycosylation using ionic tag:
Kojima, M.; Nakamura, Y.; Takeuchi, S. Tetrahedron Lett.
2007, 48, 4431. (h) Pathak, A. K.; Yerneni, C. K.; Young,
Z.; Pathak, V. Org. Lett. 2008, 10, 145.
(6) (a) Bauer, J.; Rademann, J. J. Am. Chem. Soc. 2005, 127,
7296. (b) An affinity of polyethylene glycol linker with
silica gel was used for purification of glycoside. See: Jiang,
L.; Hartley, R. C.; Chan, T.-H. Chem. Commun. 1996, 2193.
(7) The synthesis of rhamnoside by using p-dodecyloxybenzyl
ether as a protection of an alcohol at C-2 was reported. See:
Pozsgay, V. Org. Lett. 1999, 1, 477.
(8) Critchley, P.; Clarkson, G. J. Org. Biomol. Chem. 2003, 1,
4148.
(9) The Cu(OTf)2-prompted glycosylation in benzotrifluoride
was reported. See: Yamada, H.; Hayashi, T. Carbohydr. Res.
2002, 337, 581.
(12) No other products were detected in the 13C NMR spectrum
of the saccharide.
(13) In the reaction using 2-acetylated trichloroacetimidate as
glycosyl donor, an ortho ester such as 22 was produced as an
intermediate. By continuing treatment with Cu(OTf)2 (12 h),
the ortho ester was transformed to the desired glycoside
(Figure 2).
OR
O
BnO
BnO
BnO
O
O
22
Figure 2
(14) The anomeric stereochemistry of 12 was determined from
the coupling constants JCH for anomeric carbons (164 Hz).
Although the b-isomer was separable using HPLC, it was not
possible to determine the stereochemistry by NMR
(10) Eckhardt, M.; Barth, H.; Blöcker, D.; Aktories, K. J. Biol.
Chem. 2000, 275, 2328.
(11) Synthesis of Trisaccharide 8 Using an ODS Adsorption
Method – General Procedure
spectroscopy due to insufficient sample. However, as the
high-resolution mass spectrum suggested the structure of a
tetrasaccharide, we concluded the stereochemistry is b.
(15) Compound 16 was prepared in 96% yield from the
disaccharide 19 by treatment with HF·pyridine.
To a stirred suspension of Cu(OTf)2 (30 mg, 0.084 mmol)
and 4 Å MS (powder, 50 mg) in anhyd CH2Cl2 (3 mL) was
added a solution of diol 6 (300 mg, 0.42 mmol) at r.t., and
Synlett 2008, No. 13, 1981–1984 © Thieme Stuttgart · New York